A physician-supervised GLP-1 weight management program with ongoing provider follow-up.
A physician-supervised GLP-1 weight management program with ongoing provider follow-up.
Your provider reviews your health history, current medications, and goals to determine candidacy.
Baseline labs may be requested to confirm the program is appropriate for you.
Treatment begins at a low starting dose, selected by your provider.
Regular check-ins track your progress, side effects, and response.
Your provider adjusts your dose and plan based on how you are responding over time.
Every dose change is guided by your provider, not self-directed.
Starting low and increasing slowly is designed to help limit side effects.
Ongoing check-ins track your progress and any side effects.
May help reduce appetite and support portion control as part of a broader plan.
Your dosing schedule is adjusted to your individual response.
Nutrition guidance and follow-up are built into the program, not sold separately.
If hunger and portion size have made weight management difficult, semaglutide is designed to help reduce appetite, which may make it easier to follow a reduced-calorie eating plan alongside your provider’s guidance.
Semaglutide is not appropriate for everyone. It is not used with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and it is not recommended during pregnancy. Common side effects include nausea, constipation, and reduced appetite, especially after a dose increase; your provider will review the complete risk profile before you begin.
Rather than a one-time prescription, the program includes scheduled follow-up so your provider can monitor your progress, manage side effects, and adjust your dose as needed.
Medication is one part of the program. Your provider also discusses nutrition and activity habits that support the results over time.
Your starting dose and adjustments are set by your provider, not a standard schedule.
Scheduled check-ins keep your provider involved throughout treatment.
Nutrition and activity guidance are included, not add-ons.
Semaglutide is a prescription GLP-1 receptor agonist that influences appetite and fullness. It is provided only after a provider evaluation confirms it’s appropriate for you.
Candidacy depends on your health history, current medications, and goals. Your provider will review this with you at consultation, and not everyone qualifies.
Nausea, constipation, and reduced appetite are the most commonly reported effects, particularly during the first weeks and after a dose increase. Your provider will discuss the full risk profile with you.
Results vary by individual and depend on dose, adherence, and lifestyle factors. Your provider will set realistic expectations and track your progress at each follow-up.
Disclaimer: The information on this website is for general informational purposes only and is not legal, tax, accounting, insurance, or medical advice. Ma Belle Wellness and Aesthetics provides healthcare business consulting, medical director placement, company formation coordination, operational consulting, documentation preparation, and compliance support. Ma Belle Wellness and Aesthetics is not a law firm, accounting firm, insurance agency, or healthcare provider, and does not provide legal representation, tax advice, accounting services, insurance advice, or direct patient care.
Medical Directors introduced through Ma Belle Wellness and Aesthetics are independent licensed professionals who exercise their own independent medical judgment. Ma Belle Wellness and Aesthetics does not direct, supervise, or control any Medical Director’s clinical decisions. Nothing on this website creates an attorney-client, accountant-client, or physician-patient relationship. Clients are solely responsible for obtaining independent legal, tax, accounting, insurance, and regulatory advice. Read the full disclaimer.
© 2026 – Ma Belle Wellness & Aesthetics, All Rights Reserved
